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In a prospective study of 23995 Japanese women, short sleep duration was associated with higher risk of breast cancer (143 cases),
compared with women who slept 7h per day, the multivariate hazard ratio of those who slept p6h per day was 1.62 (95%
confidence interval: 1.05–2.50; P for trend¼0.03).
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Breast cancer is the commonest cancer in women, worldwide
(Parkin et al, 2005). In Japan, the incidence rate age-standardised
to the world population was 28.3 per 100000 in 1991 and 39.5
in 2001 (The Research Group for Population-based Cancer
Registration in Japan, 1998; Marugame et al, 2007).
Melatonin, which is secreted mainly from the pineal gland and
plays a role in sleep duration, is suggested as an agent in the
association between sleep duration and breast cancer (Brzezinski,
1997; Schernhammer and Schulmeister, 2004). This is because
melatonin suppresses the synthesis and secretion of sex hormones
by promoting the release of gonadotropin-releasing hormone
(Martin and Klein, 1976; Aleandri et al, 1996). In relation to
melatonin secretion, there have been several observational studies
on night work or visual impairment and breast cancer (Feychting
et al, 1998; Verkasalo et al, 1999; Kliukiene et al, 2001;
Schernhammer et al, 2001; Megdal et al, 2005; Pukkala et al,
2006; Schwartzbaum et al, 2007). In addition, there have been three
prospective cohort studies of sleep duration and the risk of breast
cancer, although with inconsistent findings (Verkasalo et al, 2005;
Pinheiro et al, 2006; Wu et al, 2008).
We therefore examined the association between sleep duration
and the risk of breast cancer in a population of Japanese women.
MATERIALS AND METHODS
Details of the Ohsaki National Health Insurance (NHI) Cohort
Study have been described previously (Tsuji et al, 1998; Kuriyama
et al, 2006). Briefly, this prospective cohort study, started in 1994,
included 28515 women aged 40–79 years living in the 14
municipalities of Miyagi Prefecture, northeastern Japan. The
response rate was 95.0% (N¼27134) for the questionnaire,
including items on sleep duration and other health-related lifestyle
factors. The study protocol was reviewed and approved by the
ethics committee of Tohoku University School of Medicine.
After exclusion of participants who had withdrawn from the
NHI before follow-up, those who had history of cancer, those who
had omitted responses for sleep duration, and those who had
reported sleep duration of less than 4h or more than 12h, 23995
participants remained. To follow up participants for mortality and
migration, we reviewed the NHI withdrawal history files for
1995–2003. Through the Miyagi Prefectural Cancer Registry, we
identified 143 incident cases of breast cancer.
With regard to the sleep duration, participants answered the
mean integer number of hours of sleep per day during the last
year. Because of the small number who slept for less than 7h and
less than 8h, we categorised sleep duration into four groups: p6,
7, 8, and X9h per day. We estimated hazard ratios (HRs) and 95%
confidence intervals (CIs) of breast cancer incidence according to
sleep duration, using the Cox proportional hazards model, with
adjustment for age and potential confounders. The continuous
P for trend was calculated by treating sleep duration as a
continuous variable, and the categorical P for trend by treating
each category as a continuous variable. Interactions between the
risk and all confounders were tested through the addition of cross-
product terms to multivariate model.
All statistical analyses were performed using SAS statistical
software, version 9.1 (SAS Institute Inc, Cary, NC, USA), and all
those reported were two-sided; differences at P-values of o0.05
were accepted as significant.
RESULTS
Table 1 shows the baseline characteristics of participants according
to sleep duration. Participants who slept 6h or less were more
likely to have a family history of cancer, to have used oral
contraceptive drugs, and to be premenopausal. Participants who
slept 9h or more were older, had a smaller total caloric intake,
lower educational level, were more likely to have a history of
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Sleep duration (hours per day)
p67 8X9
Number of participants 4549 7087 8667 3692
Mean age (years), s.d.
a 58.8 (10.5) 58.3 (10.0) 61.4 (9.3) 66.4 (8.7)
Mean body mass index (kgm
 2), s.d.
a 23.6 (3.3) 23.7 (3.3) 23.8 (3.4) 24.0 (3.9)
Mean total caloric intake (kcalday
 1), s.d.
a 1220.2 (378.8) 1263.0 (367.7) 1242.1 (380.0) 1171.8 (410.6)
History of diseases (%)
b
Presence 29.9 28.7 34.2 44.2
Absence 70.1 71.3 65.8 55.8
Family history of cancer in first-degree relatives (%)
Presence 35.0 33.1 31.1 29.7
Absence 65.0 66.9 68.9 70.3
Job (%)
Employed 35.2 38.8 32.6 23.5
Unemployed 38.0 36.1 39.5 43.6
Marital status (%)
Married 66.0 70.5 66.8 54.8
Unmarried 23.8 18.9 20.0 27.3
Education (%)
Junior high school or less 46.9 46.8 57.6 66.3
High school 36.8 39.0 29.6 18.2
College/university or higher 10.4 9.0 6.2 3.4
Cigarette smoking (%)
Never smoker 69.1 72.2 68.9 65.3
Ex-smoker 2.7 1.8 1.8 2.2
Current smoker (o20 cigarettes per day) 5.7 4.2 3.3 2.8
Current smoker (X20 cigarettes per day) 3.2 2.1 1.4 1.1
Alcohol consumption (%)
Never drinker 54.7 60.0 60.2 60.3
Ex-drinker 4.7 3.3 3.1 4.1
Current drinker 25.3 21.0 16.2 12.1
Walking status (%)
Longer than 1h per day 38.5 39.7 38.6 36.0
Less than 1h per day 52.3 51.5 51.2 51.3
Menopausal status (%)
Premenopausal 23.7 23.5 13.9 5.7
Postmenopausal 62.5 62.5 68.2 68.1
Age at menarche (%)
p13 years 7.0 7.4 6.3 5.4
14–5 years 19.5 20.5 20.7 17.0
X16 years 18.1 16.7 19.6 22.2
Age at first delivery (%)
p21 years 16.3 16.0 18.3 20.6
22–5 years 48.4 52.1 50.6 45.2
X26 years 20.6 18.8 16.1 13.1
Number of deliveries (%)
0 births 3.1 2.7 2.8 3.0
1– births 39.3 40.0 35.3 22.4
X3 births 43.6 45.4 47.2 52.7
Using of oral contraceptive drugs (%)
Yes 5.1 4.4 3.1 2.5
No 81.0 82.5 79.2 72.9
Using of hormone drugs except for oral contraceptive drugs (%)
Yes 8.1 6.8 6.3 5.7
No 77.9 79.7 76.4 69.3
astandard deviation.
bHistory of stroke, hypertension, myocardial infarction, or diabetes mellitus.
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premenopausal.
Using women who slept 7h as the reference group, we found an
inverse association between sleep duration and breast cancer
risk. The HR of women who slept 6h or less was 1.62 (95% CI:
1.05–2.50), of those who slept 8h was 1.14 (95% CI: 0.75–1.73),
and of those who slept 9h or more was 0.72 (95% CI: 0.36–1.43)
(P for trend¼0.03). This result did not change substantially when
participants whose event occurred within 3 years of baseline
(N¼49) were excluded and stratified analysis by age and
menopausal status (Table 2). In addition, we examined in detail
confounding and effect modification by other covariates on the
associations between sleep duration and the risk of breast cancer.
No statistically significant interaction was observed between sleep
duration and other confounding factors for the risk of breast
cancer on a multiplicative scale (data not shown).
DISCUSSION
This study revealed an inverse association between sleep duration
and the risk of breast cancer in Japanese women, participants who
slept 6h or daily having a significantly increased risk of breast
cancer.
There have been three prospective cohort studies of breast
cancer in relation to sleep duration (Verkasalo et al, 2005; Pinheiro
et al, 2006; Wu et al, 2008), of which the last two reported a
significantly decreased risk in long sleepers and our results are
consistent with these. By contrast, another study reported no such
association (Pinheiro et al, 2006), possibly studied because
residential nurses were studied with rotating-shift work and
varying timing of sleep, so that generalising from their results
may be inappropriate.
Melatonin is suggested to be involved in this relationship with
sleep duration, a decrease that results in a shorter duration of
nocturnal melatonin secretion (Wehr, 1991). A lower melatonin
level was associated with an increased risk of breast cancer
(Schernhammer and Hankinson, 2005; Schernhammer et al, 2008).
Melatonin may have an inhibitory effect on gonadal function,
including the synthesis and secretion of sex hormones, by
promoting the release of gonadaotropin-releasing hormone
(Martin and Klein, 1976; Aleandri et al, 1996); it also exerts an
antiproliferative effect on breast cancer cell lines (Blask et al,
1997).
Our study had several strengths. First, we recruited participants
from the general population, allowing possible generalisation of
our results. Second, the Miyagi Prefectural Cancer Registry is one
of the earliest and most accurate population-based cancer
Table 2 Cox proportional hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer incidence according to sleep duration in Japanese
women
Sleep duration (hours per day)
p67 8X9 P for trend* P for trend
w
All-cases
Person-Year 35208 55574 67368 27715
Number of event 42 40 50 11
Crude HR (95% CI) 1.66 (1.08–2.56) 1.00 (reference) 1.03 (0.68–1.56) 0.55 (0.28–1.07) 0.002 0.001
Age-adjusted HR (95% CI) 1.67 (1.08–2.58) 1.00 (reference) 1.09 (0.71–1.65) 0.63 (0.32–1.24) 0.006 0.006
Multivariable HR (95% CI)
a 1.63 (1.06–2.52) 1.00 (reference) 1.14 (0.75–1.73) 0.71 (0.36–1.41) 0.03 0.02
Multivariable HR2 (95% CI)
b 1.62 (1.05–2.50) 1.00 (reference) 1.14 (0.75–1.73) 0.72 (0.36–1.43) 0.03 0.03
Multivariable HR3 (95% CI)
c 1.67 (1.002–2.78) 1.00 (reference) 0.99 (0.59–1.65) 0.29 (0.09–0.98) 0.002 0.002
Stratified analysis
Age (P for interaction¼0.48)
o60 years
Person-Years 17048 27696 25216 5666
No. of cases 26 21 22 2
Multivariable HR (95% CI)
b 2.01 (1.12–3.59) 1.00 (reference) 1.16 (0.63–2.13) 0.43 (0.10–1.87) 0.02 0.02
X60 years
Person-Years 18160 27878 42152 22049
No. of cases 16 19 28 9
Multivariable HR (95% CI)
b 1.20 (0.61–2.35) 1.00 (reference) 1.09 (0.61–1.97) 0.81 (0.36–1.82) 0.46 0.48
Menopausal status (P for interaction¼0.70)
Premenopausal
Person-Years 8154 12907 9286 1617
No. of cases 11 8 9 0
Multivariable HR (95% CI)
b 2.06 (0.81–5.23) 1.00 (reference) 1.48 (0.56–3.93) — 0.10 0.27
Postmenopausal
Person-Years 22331 35004 46183 18933
No. of cases 28 29 35 9
Multivariable HR (95% CI)
b 1.46 (0.86–2.46) 1.00 (reference) 1.04 (0.63–1.70) 0.74 (0.35–1.59) 0.11 0.09
*P for trend values were calculated by treating sleep duration as a continuous variable.
wP for trend values were calculated by treating each categories of sleep duration as a
continuous variable.
aMultivariable HR was adjusted for age (continuous variable); body mass index (o18.5, 18.5–25.0, X25.0kgm
 2); history of diseases (having history of
stroke, hypertension, myocardial infarction, or diabetes mellitus); family history of cancer (presence or absence in first-degree relatives); job (employed or unemployed); marital
status (married or unmarried); education (junior high school or less, high school, or college/university or higher); cigarette smoking (never smoker, ex-smoker, current smoker 1–
19 cigarettes per day, or current smoker X20 cigarettes per day); alcohol consumption (never drinker, ex-drinker, or current drinker); time spent walking (less than 1h per day,
or longer than 1h per day).
bMultivariable HR2 was adjusted for above plus total caloric intake (continuous variable, kcalday
 1); menopausal status (premenopausal or
postmenopausal); age at menarche (p13 years, 14–15 years, or X16 years); age at first delivery (p21 years, 22–25 years, or X26 years); number of deliveries (0 births, 1–2
births, or X3 births); using of oral contraceptive drugs (yes or no); using of hormone drugs except for oral contraceptive drugs (yes or no).
cMultivariable HR3 denotes the HR2
with cases diagnosed in the first 3 years of follow-up excluded from the analysis.
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breast cancer cases ascertained by death certificate only (DCO) in
1998–2002 (Curado et al, 2007).
Our study also had several methodological limitations. First, we
used self-reported sleep duration, and the assessment was done
only once. Second, we had no information on such factors as sleep
quality, the timing of sleep, the use of sleep medication, or the
presence of sleeping disorders that can influence sleep duration
and thereby might affect breast cancer risk. Finally, we had no
information about rotating-shift work or night work, but since
23% of our participants were housewives, 19.0% farmers, and
15.7% retired, such details would have been unlikely to have
changed the result substantially.
In conclusion, we have found a significant inverse association
between sleep duration and breast cancer risk in Japanese women,
those who slept 6h or less having a significantly increased risk.
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